• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状寡腺苷酸依赖的 CRISPR 核糖核酸酶 Csm6 的激活和自我失活机制。

Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6.

机构信息

Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.

Biolog Life Science Institute GmbH & Co. KG, Flughafendamm 9a, D-28199, Bremen, Germany.

出版信息

Nat Commun. 2020 Mar 27;11(1):1596. doi: 10.1038/s41467-020-15334-5.

DOI:10.1038/s41467-020-15334-5
PMID:32221291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7101355/
Abstract

Bacterial and archaeal CRISPR-Cas systems provide RNA-guided immunity against genetic invaders such as bacteriophages and plasmids. Upon target RNA recognition, type III CRISPR-Cas systems produce cyclic-oligoadenylate second messengers that activate downstream effectors, including Csm6 ribonucleases, via their CARF domains. Here, we show that Enteroccocus italicus Csm6 (EiCsm6) degrades its cognate cyclic hexa-AMP (cA6) activator, and report the crystal structure of EiCsm6 bound to a cA6 mimic. Our structural, biochemical, and in vivo functional assays reveal how cA6 recognition by the CARF domain activates the Csm6 HEPN domains for collateral RNA degradation, and how CARF domain-mediated cA6 cleavage provides an intrinsic off-switch to limit Csm6 activity in the absence of ring nucleases. These mechanisms facilitate rapid invader clearance and ensure termination of CRISPR interference to limit self-toxicity.

摘要

细菌和古菌的 CRISPR-Cas 系统为抵御噬菌体和质粒等遗传入侵物提供了 RNA 导向的免疫。在靶 RNA 识别后,III 型 CRISPR-Cas 系统产生环状寡聚腺苷酸第二信使,通过其 CARF 结构域激活下游效应物,包括 Csm6 核糖核酸酶。在这里,我们表明肠球菌意大利亚种 Csm6(EiCsm6)降解其同源环状六聚 AMP(cA6)激活剂,并报告了与 cA6 模拟物结合的 EiCsm6 的晶体结构。我们的结构、生化和体内功能测定揭示了 CARF 结构域如何识别 cA6 以激活 Csm6 的 HEPN 结构域进行副产物 RNA 降解,以及 CARF 结构域介导的 cA6 切割如何为 Csm6 活性提供内在的关闭开关,从而在没有环核酶的情况下限制 Csm6 活性。这些机制有助于快速清除入侵物,并确保 CRISPR 干扰的终止以限制自我毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/4a5c05bc74a6/41467_2020_15334_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/7415ae53279a/41467_2020_15334_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/fe6a1132cfbe/41467_2020_15334_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/c6671b30e855/41467_2020_15334_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/4a5c05bc74a6/41467_2020_15334_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/7415ae53279a/41467_2020_15334_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/fe6a1132cfbe/41467_2020_15334_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/c6671b30e855/41467_2020_15334_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d26/7101355/4a5c05bc74a6/41467_2020_15334_Fig4_HTML.jpg

相似文献

1
Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6.环状寡腺苷酸依赖的 CRISPR 核糖核酸酶 Csm6 的激活和自我失活机制。
Nat Commun. 2020 Mar 27;11(1):1596. doi: 10.1038/s41467-020-15334-5.
2
CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA Cleavage with ApA>p Formation Terminating RNase Activity.CRISPR-Cas III-A Csm6的CARF结构域是一种环状核酸酶,可引发逐步的cA切割,形成ApA>p从而终止核糖核酸酶活性。
Mol Cell. 2019 Sep 5;75(5):944-956.e6. doi: 10.1016/j.molcel.2019.06.014. Epub 2019 Jul 17.
3
Structural basis of cyclic oligoadenylate degradation by ancillary Type III CRISPR-Cas ring nucleases.辅助型 III 类 CRISPR-Cas 环核酶降解环寡腺苷酸的结构基础。
Nucleic Acids Res. 2021 Dec 2;49(21):12577-12590. doi: 10.1093/nar/gkab1130.
4
Type III-A CRISPR-associated protein Csm6 degrades cyclic hexa-adenylate activator using both CARF and HEPN domains.III-A 型 CRISPR 相关蛋白 Csm6 使用 CARF 和 HEPN 结构域降解环状六腺苷酸激活剂。
Nucleic Acids Res. 2020 Sep 18;48(16):9204-9217. doi: 10.1093/nar/gkaa634.
5
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.III 型 CRISPR-Cas 系统产生环状寡聚腺苷酸第二信使。
Nature. 2017 Aug 31;548(7669):543-548. doi: 10.1038/nature23467. Epub 2017 Jul 19.
6
Regulation of cyclic oligoadenylate synthesis by the Cas10-Csm complex.Cas10-Csm 复合物对环寡腺苷酸合成的调控。
RNA. 2019 Aug;25(8):948-962. doi: 10.1261/rna.070417.119. Epub 2019 May 10.
7
A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator.一种 III 型 CRISPR 辅助核糖核酸酶降解其环状寡腺苷酸激活剂。
J Mol Biol. 2019 Jul 12;431(15):2894-2899. doi: 10.1016/j.jmb.2019.04.041. Epub 2019 May 6.
8
Activation of Csm6 ribonuclease by cyclic nucleotide binding: in an emergency, twist to open.环核苷酸结合激活 Csm6 核糖核酸酶:紧急情况下,扭曲以打开。
Nucleic Acids Res. 2023 Oct 27;51(19):10590-10605. doi: 10.1093/nar/gkad739.
9
Investigation of the cyclic oligoadenylate signaling pathway of type III CRISPR systems.III型CRISPR系统环状寡腺苷酸信号通路的研究
Methods Enzymol. 2019;616:191-218. doi: 10.1016/bs.mie.2018.10.020. Epub 2019 Jan 12.
10
A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems.III 型 CRISPR-Cas 系统中的环状寡核苷酸信号通路。
Science. 2017 Aug 11;357(6351):605-609. doi: 10.1126/science.aao0100. Epub 2017 Jun 29.

引用本文的文献

1
Diversity and abundance of ring nucleases in type III CRISPR-Cas loci.III型CRISPR-Cas基因座中环状核酸酶的多样性和丰度
Philos Trans R Soc Lond B Biol Sci. 2025 Sep 4;380(1934):20240084. doi: 10.1098/rstb.2024.0084.
2
SAM-AMP lyases in type III CRISPR defence.III型CRISPR防御中的SAM-AMP裂解酶
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf655.
3
CARF-dependent preferential RNA cleavage by Csm6 increases drug susceptibility of mycobacteria.Csm6依赖CARF的RNA优先切割增加了分枝杆菌对药物的敏感性。
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf622.
4
Inhibitors of Cyclic Dinucleotide Phosphodiesterases and Cyclic Oligonucleotide Ring Nucleases as Potential Drugs for Various Diseases.环二核苷酸磷酸二酯酶和环寡核苷酸环核酸酶抑制剂作为多种疾病的潜在药物
Cells. 2025 Apr 30;14(9):663. doi: 10.3390/cells14090663.
5
Mechanistic determinants and dynamics of cA6 synthesis in type III CRISPR-Cas effector complexes.III型CRISPR-Cas效应复合物中cA6合成的机制决定因素和动力学
Nucleic Acids Res. 2025 Jan 11;53(2). doi: 10.1093/nar/gkae1277.
6
AcrIIIA1 is a protein-RNA anti-CRISPR complex that targets core Cas and accessory nucleases.AcrIIIA1是一种蛋白质-RNA抗CRISPR复合物,其靶向核心Cas和辅助核酸酶。
Nucleic Acids Res. 2024 Dec 11;52(22):13490-13514. doi: 10.1093/nar/gkae1006.
7
Current Updates of CRISPR/Cas System and Anti-CRISPR Proteins: Innovative Applications to Improve the Genome Editing Strategies.CRISPR/Cas 系统和抗 CRISPR 蛋白的最新进展:创新应用以改善基因组编辑策略。
Int J Nanomedicine. 2024 Oct 9;19:10185-10212. doi: 10.2147/IJN.S479068. eCollection 2024.
8
Nucleotide Immune Signaling in CBASS, Pycsar, Thoeris, and CRISPR Antiphage Defense.核苷酸免疫信号在 CBASS、Pycsar、Thoeris 和 CRISPR 抗噬菌体防御中的作用。
Annu Rev Microbiol. 2024 Nov;78(1):255-276. doi: 10.1146/annurev-micro-041222-024843. Epub 2024 Nov 7.
9
Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system.结构洞察 III 型 CRISPR 系统中的 Csx1-Crn2 融合自我限制核糖核酸酶。
Nucleic Acids Res. 2024 Aug 12;52(14):8419-8430. doi: 10.1093/nar/gkae569.
10
Nanopores Reveal the Stoichiometry of Single Oligoadenylates Produced by Type III CRISPR-Cas.纳米孔揭示了 III 型 CRISPR-Cas 产生的单聚腺苷酸的化学计量。
ACS Nano. 2024 Jul 2;18(26):16505-16515. doi: 10.1021/acsnano.3c11769. Epub 2024 Jun 14.